The findings from the first Phase 3 study to assess the effect of a reversal agent for a specific NOAC in real-world emergency settings have been announced. …
Latest Video
New Stories
-
Cyclopharm sigs agreement makes major progress with US veterans and defence administrations
October 6, 2024 - - Latest News -
New drug could be answer to an overlooked yet devastating type of dementia
October 6, 2024 - - Latest News -
Island Pharmaceuticals secures new funding to support key inflection points and pipeline build
October 6, 2024 - - Latest News -
Otsuka celebrates its tenth anniversary in Australia
October 4, 2024 - - Latest News -
The 'Dispatched' Week in Review Podcast - 4 October
October 3, 2024 - - Podcast -
Women’s health collaboration calls for MBS reform to improve access to contraception
October 3, 2024 - - Latest News -
Rare disease company Sobi appoints new general manager for Australia and New Zealand
October 3, 2024 - - Latest News